期刊文献+

健脾益气清热活血法联合不同免疫抑制剂治疗IMN临床疗效及安全性评估 被引量:3

Clinical efficacy and safety evaluation of Jianpi Yiqi Qingre Huoxue decoction combined with different immunosuppressive agents in the treatment of IMN
暂未订购
导出
摘要 目的观察中药健脾益气清热活血法分别联合环磷酰胺(cyclophos-phamide,CTX)及环孢素A治疗特发性膜性肾病(idiopathic membranous nepropathy,IMN)的疗效及安全性。方法选取我院及合作单位肾内科2015年7月~2017年7月符合入选标准的IMN患者80例,平均分为4组,A1组为中药联合环磷酰胺组、A2组为环磷酰胺组、B1组为中药联合环孢素A组、B2组为环孢素A组。观察A1、A2两组及B1、B2两组患者治疗前后的血清白蛋白、24 h尿蛋白定量、血肌酐等疗效性指标以及肝功能、血常规等安全性指标。结果治疗3个月后,A1组在24 h尿蛋白、血清白蛋白、总胆固醇水平改善情况较治疗前及A2组明显(P<0.05);治疗6个月后,A1组24 h尿蛋白定量、总胆固醇较治疗前明显下降(P<0.01),血清白蛋白水平高于治疗前(P<0.01),较A2组相关指标改善更为显著(P<0.05),A1组6个月总有效率高于A2组(P<0.05);治疗3个月后,B1组在24 h尿蛋白定量、总胆固醇、血清白蛋白改善情况较治疗前及B2组明显(P<0.05);治疗6个月后,B1组上述指标改善情况显著高于B2(P<0.01),B1组6个月总有效率高于B2组(P<0.05)。结论中药健脾益气清热活血法联合免疫抑制剂临床疗效优于单纯使用免疫抑制剂,且安全性良好。 Objective To observe the efficacy and safety of traditional Chinese medicine Jianpi Yiqi Qingre Huoxue decoction combined with cyclophosphine-phamide(CTX)or cyclosporine A in the treatment of idiopathic membranous nephropathy(IMN).Methods 80 patients with IMN who met the inclusion criteria from July 2015 to July 2017 in the Department of Nephrology in our hospital and partner unit were enrolled.The patients were divided into 4 groups.The A1 group was Chinese medicine combined with cyclophosphamide group and the A2 group was cyclophosphamide group.B1 group was Chinese medicine combined with cyclosporine A group,and B2 group was cyclosporine A group.The serum albumin,24h urine protein quantitation,serum creatinine and other therapeutic indicators,as well as liver function,blood routine,CRP,endogenous creatinine clearance and other safety indicators were observed before and after treatment in the group A1,A2,B1 and B2.Results After 3 months of treatment,the improvement of urine protein,serum albumin and total cholesterol in the A1 group was significantly higher than that in the A2 group and that before treatment(P<0.05).After 6 months of treatment,the 24 hour urine protein quantitation and the total cholesterol in the A1 group was significantly lower than that before treatment(P<0.01),and the serum albumin level was higher than that before treatment(P<0.01),which was more significant than that of the A2 group(P<0.05).The 6 months total efficiency in the A1 group was higher than that of A2 group(P<0.05).After 3 months of treatment,the improvement of 24h urine protein,total cholesterol and serum albumin in B1 group was significantly higher than that before treatment and B2 group(P<0.05).And after 6 months of treatment,the improvement of the above indicators in the B1 group was significantly higher than that in the B2 group(P<0.01),and the total effective rate in the 6 months in the B1 group was higher than that in the B2 group(P<0.05).Conclusion The clinical efficacy of traditional Chinese medicine Jianpi Yiqi Qingre Huoxue decoction ccombined with immunosuppressive agent is better than that of immunosuppressive agent alone,and the safety is good.
作者 娄成利 徐业 黄科 赵俊 王力勇 何立群 LOU Chengli;XU Ye;HUANG Ke;ZHAO Jun;WANG Liyong;HE Liqun(Department of Nephrology,Jiaxing Traditional Chinese Medicine Hospital in Zhejiang Province,Jiaxing 314000,China;Department of Nephrology,Shuguang Hospital Affiliated to ShanghaiUniversity of Traditional Chinese Medicine,Shanghai 200021,China)
出处 《中国现代医生》 2019年第9期124-127,130,共5页 China Modern Doctor
基金 浙江省中医药科研基金项目(2016ZB126)
关键词 健脾益气清热活血法 特发性膜性肾病 免疫抑制剂 安全性 Jianpi Yiqi Qingre Huoxue method Idiopathic membranous nephropathy Immunosuppressive agent Safety
  • 相关文献

参考文献10

二级参考文献47

  • 1任国辉,叶任高.中西医结合治疗原发性膜性肾炎肾病综合征30例临床观察[J].广东医学,1995,16(11):761-763. 被引量:10
  • 2<环孢素A在肾内科的应用>专家协作组.环孢素A治疗肾小球疾病的应用共识[J].中华肾脏病杂志,2005,21(9):556-557. 被引量:73
  • 3Cattran DC, Greenwood C, Ritchie S. et al. A controlled trial of eyclosporine in patients with progressive membranous nephropa- thy. Candian Glomerulonephritis Stndy Group. Kidney Int, 1995, 47(4) :1130 - 1135.
  • 4Warwick GL, Geddes CG, Bouhon - Jones JM. Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure. Q J Med, 1994,87 (4) : 223 - 229.
  • 5Cattran DC, Appel GB, Hebert LA, et. al. Cyclosporine in pa- tients with steroid - resistant membranous nephropathy: a ran- domized triM. Kidney Int,2001,59(4) :1484 - 1490.
  • 6Cattan DC, Appel GB, Hebert LA, et al. A randomized trial of Cy- closporine in patients with focal segmental glomerulosclerosis. Noreh America Nephrotie Syudrome Study Group. Kidney Int, 1999,56 (6) : 2220 - 2226.
  • 7Perna A, Schieppati A, Zamora J, et al. Immunosuppressive treatment for idiopathic membranous nephropathy:a systematic review[ J ].Am J Kidney Dis, 2004,44 (3) : 385-401.
  • 8Hudson M, Thombs BD, Steele R, et al.Health-related quality of life in systemic sclerosis: a systematic review[J].Arthritis Rheum, 2009, 61(8): 1112-1120.
  • 9Prasad N, Gulati S, Sharma RK, et al. Pulse cyclophosphamide therapy in steroid dependent nephrotic syndrome [J]. Pediatr Nephrol, 2004, 19(5): 494-498.
  • 10Beretta L, Caronni M, Raimondi M, et al. Oral cyelopphamide improves pulmonary function in selerodenna patients with fibrosing alveolitis: experience in one centre[J].Clin Rheunaatol, 2007, 26(2): 168-172.

共引文献174

同被引文献42

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部